FDA warns of steroids in vitamin B supplement

(AP)—The Food and Drug Administration is warning consumers to avoid a vitamin B dietary supplement from Healthy Life Chemistry by Purity First because it contains two potentially dangerous anabolic steroids.

The agency says the company's B-50 supplements tested positive for methasterone and dimethazine, two steroids sometimes used illegally by bodybuilders. Neither ingredient is listed on the product's labeling.

Federal regulators have received 29 reports of side effects connected with the product, including fatigue, muscle cramping and pain. Some of the cases have resulted in hospitalization, but there have been no reports of death or liver failure.

The product is manufactured by Mira Health Products Ltd. of Farmingdale, N.Y. and sold online and in stores. The FDA says the company has declined a government request to voluntarily recall the product.

5 /5 (2 votes)
add to favorites email to friend print save as pdf

Related Stories

FDA warns consumers of dangers of the stimulant DMAA

Apr 15, 2013

(HealthDay)—The U.S. Food and Drug Administration is attempting to halt distribution of dietary supplements that contain the stimulant dimethylamylamine (DMAA), following reports of illness and death associated ...

US cracks down on illegal diabetes remedies

Jul 23, 2013

(AP)—The Food and Drug Administration is cracking down on more than a dozen U.S. and foreign companies that market illegal treatments for diabetes, ranging from bogus dietary supplements to prescription ...

US warns of drugs in Reumofan dietary supplements

Aug 21, 2012

(AP) — The U.S. Food and Drug Administration is warning consumers not to use Reumofan dietary supplements, after receiving reports of bleeding, stroke and death among Americans taking the Mexico-manufactured pills.

Recommended for you

Express Scripts turns to AbbVie in huge hepatitis C deal

13 hours ago

The nation's largest pharmacy benefits manager is throwing its weight into the fight over high-cost hepatitis C drugs with a coverage restriction that might ultimately lower prices and improve patient access ...

FDA OKs Cubist antibiotic for serious infections

Dec 20, 2014

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.